Larimar Therapeutics, Inc. · NASDAQ:LRMR

Sherman Jeffrey W bought 3,289 Larimar Therapeutics, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 16, 2026

On Nov 16, 2026, Sherman Jeffrey W (Director) bought 3,289 Larimar Therapeutics, Inc. shares at US$3.06 for US$10,058, leaving 8,289 shares. Filed Nov 16, 2026 (Form 4).

Bought
3,289 shares
Price
US$3.06
Value
US$10,058
Holding after
8,289 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockBuy3,289US$3.068,289Direct

Source

Download original · View original at SEC

Related